Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,841 | 11,586 | 16,356 | 8,002 | 22,342 |
| Marketable Securities | 21,950 | 23,209 | 26,270 | 15,624 | 6,191 |
| Receivables | 199 | 347 | 237 | 144 | 258 |
| Other current assets | 139 | 96 | 134 | 187 | 266 |
| TOTAL | $34,492 | $37,229 | $44,399 | $25,432 | $30,933 |
| Non-Current Assets | |||||
| PPE Net | 80 | 86 | 91 | 87 | 60 |
| Other Non-Current Assets | 158 | 159 | 159 | 514 | 203 |
| TOTAL | $238 | $245 | $250 | $601 | $263 |
| Total Assets | $34,730 | $37,474 | $44,649 | $26,033 | $31,196 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,403 | 1,355 | 1,193 | 795 | 410 |
| Accounts payable and accrued liabilities | 1,559 | 2,120 | 1,083 | 1,298 | 1,105 |
| Accrued Expenses | 2,998 | 3,388 | 3,990 | 2,776 | 2,368 |
| Other current liabilities | 7,704 | 13,596 | 8,766 | 8,888 | 11,638 |
| TOTAL | $13,664 | $20,459 | $15,032 | $13,757 | $15,521 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,784 | 3,152 | 3,476 | 3,793 | 4,099 |
| Other Non-Current Liabilities | 14 | 13 | 10 | 6 | 200 |
| TOTAL | $2,798 | $3,165 | $3,486 | $3,799 | $4,299 |
| Total Liabilities | $16,462 | $23,624 | $18,518 | $17,556 | $19,820 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,259 | 15,240 | 14,687 | 14,665 | 10,065 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -383,087 | -380,759 | -368,037 | -362,076 | -358,904 |
| Other shareholders' equity | -7 | -14 | -15 | 0 | 3 |
| TOTAL | $18,268 | $13,850 | $26,131 | $8,477 | $11,376 |
| Total Liabilities And Equity | $34,730 | $37,474 | $44,649 | $26,033 | $31,196 |